A PDE6δ-KRas Inhibitor Chemotype with up to Seven H-Bonds and Picomolar Affinity that Prevents Efficient Inhibitor Release by Arl2.
about
Hypertonicity-induced cation channels (HICCs) in HepG2 cells: architecture and role in proliferation vs. apoptosis.Recent advances in the biology and therapy of medullary thyroid carcinoma.Inhibition of KRAS-dependent lung cancer cell growth by deltarasin: blockage of autophagy increases its cytotoxicity.Small-Molecule Modulation of Lipid-Dependent Cellular Processes against Cancer: Fats on the Gunpoint
P2860
A PDE6δ-KRas Inhibitor Chemotype with up to Seven H-Bonds and Picomolar Affinity that Prevents Efficient Inhibitor Release by Arl2.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
A PDE6δ-KRas Inhibitor Chemoty ...... ent Inhibitor Release by Arl2.
@en
A PDE6δ-KRas Inhibitor Chemoty ...... ent Inhibitor Release by Arl2.
@nl
type
label
A PDE6δ-KRas Inhibitor Chemoty ...... ent Inhibitor Release by Arl2.
@en
A PDE6δ-KRas Inhibitor Chemoty ...... ent Inhibitor Release by Arl2.
@nl
prefLabel
A PDE6δ-KRas Inhibitor Chemoty ...... ent Inhibitor Release by Arl2.
@en
A PDE6δ-KRas Inhibitor Chemoty ...... ent Inhibitor Release by Arl2.
@nl
P2093
P2860
P50
P356
P1476
A PDE6δ-KRas Inhibitor Chemoty ...... ent Inhibitor Release by Arl2.
@en
P2093
Christian H Klein
Eyad K Fansa
Malte Metz
Marc Schürmann
Matthias Baumann
Petra Janning
Philippe I H Bastiaens
Sandip Murarka
P2860
P304
P356
10.1002/ANIE.201610957
P407
P577
2017-01-20T00:00:00Z